CME4HD Older Content

Huntington disease (HD) is a treatable, family disease

HSG’s CME4HD is an in-person continuing medical education program designed to teach healthcare providers how to care for and manage individuals with Huntington disease (HD), hosted by the Huntington Study Group (HSG). Attendees will gain the knowledge, tools, and resources they need to provide excellent care to families impacted by HD, and they learn from world experts in HD care.


After completing this activity, participants should be able to:

  • Core features of Huntington disease with an up-to-date understanding of the diagnosis, staging, and typical symptoms of HD, as well as approaches to treatment;
  • Ethical dilemmas in genetic testing and current options in reproductive technologies for HD patients and families;
  • Strategies for behavioral, psychiatric/cognitive, and neurological management of the disease, as well as symptom identification and care options;
  • Translation of complex clinical information to patients and family, the development of therapeutic relationships, and possess an understanding of available support resources;
  • And the role of ancillary services such as rehabilitation therapies, genetics, psychology, and social services, in the management of HD.

This activity is designed for healthcare professionals, including social workers, nurses, and neurologists, who provide care to patients with Huntington’s disease.


In support of improving patient care, this activity has been planned and implemented by North American Center for Continuing Medical Education (NACCME) and Huntington Study Group. NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


NACCME designates this live activity for a maximum of 4 AMA PRA Category 1 Credit™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.


This continuing nurse education activity awards 4 contact hours.

Provider approved by the California Board of Registered Nursing. Provider #13255 for 4 contact hours.

CME4HD occurred on Saturday, Nov. 4, 2017 at the Hyatt Regency Denver Colorado Conference Center, Denver, CO.

To be eligible for documentation of credit, participants must complete the online evaluation form at All individuals who participate in the conference and submit the completed evaluation form online may immediately print their documentation of credit.

For questions regarding this educational activity, please call HSG at +1 800-487-7671.


Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Huntington Study Group prior to the live event at info@hsglimited.orgor +1 800-487-7671.

This activity is jointly provided by North American Center for Continuing Medical Education (NACCME) and Huntington Study Group.


This activity has been supported through in independent educational grant from Teva Pharmaceuticals.

Course faculty include:

  • Daniel Claassen, MD, associate professor of Neurology, Vanderbilt University
  • Mary Edmondson, MD, psychiatrist and medical director, HD Reach
  • Rebecca Ferrini, MD, MPH, medical director, Edgemoor Distinct Part Skilled Nursing Facility (DP SNF)
  • Martha Nance, MD, neurologist, clinical geneticist and medical director, Struthers Parkinsons Center
  • Vicki Wheelock, MD, clinical professor and director of the HDSA Center of Excellence, University of California Davis

The course is open to any interested healthcare professionals, including primary care physicians, neurologists, psychiatrists, psychologists, nurses, social workers, genetic counselors, and physical and occupational therapists.

To see past education programs, click here.

Were you unable to join us in-person? Click here to access our primer videos to provide knowledgeable care to HD patients and families.